StratDeck

Two stocks in Basic Materials

Holcim vs Novonesis A/S: profit, growth, debt and price compared

Novonesis A/S is stronger on 4 of 7 figures: profit margin, sales growth, debt and price trend. Holcim is stronger on 2: price for its expected profit and dividend.

Figures as of 18 November 2026Yahoo Finance
Explore Holcim's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Holcim and Novonesis A/S side by side
HolcimHOLN.SWNovonesis A/SNSIS-B.CO
Net margin2.4%Stronger: 15.6%
Revenue growth, past year+0.70%Stronger: +7.10%
Debt to equity65.6%Stronger: 27.9%
Forward P/EStronger: 17.2×26.0×
Dividend yieldStronger: 2.28%1.46%
AnalystsBuy · 19Buy · 15
From its 200-day average+5.5%Stronger: +6.9%

Share price over the past year

  • Holcim+4.9%
  • Novonesis A/S+10.2%

17 Nov 202518 Nov 2026

Holcim or Novonesis A/S: which is stronger?

  • NSIS-B.CO

    Which is more profitable?

    Novonesis A/S keeps more of each sale as profit: 15.6% against 2.4%.

  • NSIS-B.CO

    Which is growing its sales faster?

    Novonesis A/S is growing its sales faster: +7.10% over the past year, against +0.70%.

  • NSIS-B.CO

    Which has borrowed less?

    Novonesis A/S has borrowed less: its debt is 27.9% of what its shareholders own, against 65.6% for Holcim.

  • HOLN.SW

    Which costs less for the profit it is expected to make?

    Holcim costs less for the profit it is expected to make: 17.2× its forward earnings, against 26.0×.

  • HOLN.SW

    Which pays more in dividends?

    Holcim pays more back in dividends for what a share costs: 2.28% a year, against 1.46%.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • NSIS-B.CO

    Which is in the stronger price trend?

    Novonesis A/S' price is in the stronger trend: 6.9% above its 200-day average, against 5.5% above.

What each company does

HOLN.SWHolcim

Holcim AG, together with its subsidiaries, provides building materials and solutions in Europe, Latin America, and Asia, Middle East, and Africa.

Reports results on 25 February 2027

NSIS-B.CONovonesis A/S

Novonesis A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America.

Reports results on 24 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every European basic materials comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.